Arik Ishay Is Marching To The Biobeat Of His Own Drum

Biobeat defies the usual trend of start-ups seeking ever-growing sums of capital before either going public or being acquired. Its CEO, Arik Ben Ishay, believes the company can quickly become self-sufficient by tackling endemic problems.

• Source: Shutterstock

More from Cardiology

More from Device Area